Press Release

ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy

Truvian: Independent Study Highlights Robustness and Ease-of-Use of Truvian’s Blood Testing Platform in a Real-World Clinical Setting

Aspen Neuroscience: Study of ANPD001 Autologous Neuronal Cell Replacement Treatment Approach Published in Journal of Neurosurgery

Truvian Health raises $74M to bring blood testing to anyone, anywhere

SonoThera™ to Present Late Breakthrough Data at ISTH 2024 on Development of Nonviral Hemophilia A Gene Therapy Treatment

ProJenX Announces Receipt of $1M Hoffman ALS Clinical Trial Award from the ALS Association

Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting

Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)

AVILAR THERAPEUTICS TO PRESENT PRECLINICAL DATA FOR MTAC (M6PR TARGETING CHIMERA) EXTRACELLULAR PROTEIN DEGRADER PLATFORM AT THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS ANNUAL MEETING